Antiretroviral therapy coverage for PMTCT in Portugal
Portugal: Antiretroviral therapy coverage for PMTCT was 96.0% in 2009. ▬ Flat
Antiretroviral therapy coverage for PMTCT in Portugal, 2000–2009
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage for pmtct in Portugal is 96.0%, measured in 2009. That is the highest value across all 10 years on record.
Compared with earlier readings it is up 1.1% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Portugal peaked at 96.0% in 2006 and was at its lowest, 95.0%, in 2000.
That places Portugal 15th out of 84 countries with data for 2009, putting it in the top quarter.
Antiretroviral therapy coverage for PMTCT in Portugal, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 95.0% | — |
| 2001 | 95.0% | +0.0% |
| 2002 | 95.0% | +0.0% |
| 2003 | 95.0% | +0.0% |
| 2004 | 95.0% | +0.0% |
| 2005 | 95.0% | +0.0% |
| 2006 | 96.0% | +1.1% |
| 2007 | 96.0% | +0.0% |
| 2008 | 96.0% | +0.0% |
| 2009 | 96.0% | +0.0% |
Portugal compared with similar countries
- Portugal's 96.0% is above the median for high income countries, which is 89.0%, 1.1× the median. (8 countries reporting)
- Portugal's 96.0% is above the median for Europe & Central Asia, which is 91.0%, 1.1× the median. (8 countries reporting)
Countries ranked near Portugal
More health data for Portugal
- Un projection of annual infant deaths, annual growth rate -2.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1616 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,112 deaths per 1,000 people (2090)
- Number of infants who die before age 1 38 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.39 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0199 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.15 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Portugal?
- Antiretroviral therapy coverage for pmtct in Portugal was 96.0% in 2009, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Portugal?
- The highest recorded value was 96.0% in 2006.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Portugal?
- The lowest recorded value was 95.0% in 2000.
- How does Portugal rank for antiretroviral therapy coverage for pmtct?
- Portugal ranks 15th out of 84 countries with data for 2009.
- Is antiretroviral therapy coverage for pmtct rising or falling in Portugal?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is flat.
- Where does this Portugal data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).